Senior Program Strategy and Operations Director, Enveda
$276-300k
Drug discovery & development platform
Be an early applicant
Drug discovery & development platform
201-500 employees
Be an early applicant
$276-300k
201-500 employees
Company mission
To bring home to and improve the health of people everywhere.
Role
Who you are
- If you’ve ever wished you could combine the discipline of program management with the strategic thinking, creativity and agency of a startup leader - and operate like the COO of a single-asset biotech – this is that opportunity
- Experienced in biotech or pharma program management, portfolio or asset strategy, management consulting, or operations - and able to use this experience to help your program avoid missteps
- Fluent with AI, using it from the start of your workflow not as a novelty, but as a multiplier of human judgment and creativity
- A crisp communicator, able to synthesize information across disciplines to propose clear, compelling options, laid out in concise slides / memos supported by clear data analysis
- Willing to roll up your sleeves and make things happen yourself, when needed, regardless of title: gaps don’t linger in your perimeter and you can’t rest until they’re resolved
- Used to thriving in ambiguity and moving fluidly between strategic vision and tactical execution
- Emotionally intelligent, humble, and honest, leading through collaboration, not control
- Intellectually curious, analytically rigorous, and can bring an optimism that lifts the team
- We hire for trajectory, not just credentials. If you meet most of the above and care deeply about this problem, we want to hear from you
- This role is remote, though will necessarily involve travel on a roughly monthly basis to meet the team and key external stakeholders
What the job involves
- At Enveda, we’re reinventing drug development: not just with our discovery and development platform, but also in our approach to culture and organization
- Our Program Strategy & Operations (PSO) leaders are not simply trackers of timelines, they are strategic and operational copilots to the Asset Entrepreneurs driving their molecule
- You will be the connective tissue across the single-threaded asset team, transforming rich, cross-functional information into sharper strategy, better decision-making with our C-suite, and faster, higher-quality execution, directly determining how quickly we bring our first-in-class natural-molecule-inspired medicines to the patients who need them most
- We think of this role as an Asset Entrepreneur in the making, bringing a founder mentality from the start; you will be judged on the speed and quality of the asset's decisions and the progress that follows, not on how many meetings you run
- In this role, you will report to the Asset Entrepreneur and be accountable for:
- Operating as a strategic thought partner to your Asset Entrepreneur, anticipating program inflection points, modeling backup and expansion scenarios, and helping determine when to accelerate, pivot, or pause aspects of the development plan based on data and risk
- Owning program execution end-to-end, operating like the COO of a single-asset biotech: rapidly identifying obstacles and doing whatever is needed to keep the program moving, be that coordinating across functions, rallying CRO partners, or designing dashboards to keep all aligned
- Translating complexity into clarity by distilling scientific, clinical, regulatory, and operational inputs into rigorous analytical insights and clearly communicated options for the Board and C-suite, including crisp, data-driven slides/memos
- Maintaining disciplined documentation and operational clarity, capturing key decisions, assumptions, and benchmarks while keeping dashboards, trackers, and updates accurate, accessible, and action-ready for asynchronous alignment
- Contributing to Enveda’s institutional intelligence and playbook, documenting benchmarks, best practices, and learnings that make each future program faster and smarter
- Longitudinal asset development from IND-enabling studies through commercial strategy
- Full cross-functional operations, working shoulder-to-shoulder with clinical, translational, regulatory, CMC, and commercial experts
- External engagement, selecting and managing our external vendors, advisors, and strategic partners, and building a presence among our disease area’s top thinkers
- Board and investor engagement, embedding in our investor and business development (BD) processes and seeing first-hand how biotechs grow
- Scientific storytelling, helping to discover, craft, and tell the narrative of new molecules that often bring novel biology into the therapeutic world, requiring substantial education of patients, clinicians, and investors
- Company building and culture creation, as we write the playbook and growing body of operational knowledge in a nascent biotech on the path to a new, multi-disease, multi-mechanism commercial future
- In short, you’ll sit at the intersection of strategy, science, and operations, where decisions visibly move both the program and the company
Application process
- Our Process: We move fast and respect your time. Typically: a recruiter screen → hiring manager conversation → work sample, technical interview, & culture interview
Our take
Despite massive innovations in healthcare of late, drug discovery is still an arduous process, and a huge amount of the natural world remains unexplored for medicinal molecules. Enveda delivers a platform to rapidly probe for new medically active compounds, creating the world's "most diverse biologically annotated dataset of small molecules".
With Enveda's AI and ML-led technology, the chemical structure and biological activity of molecules can be assessed at speed and scale, using high-throughput experiments to generate the dataset that can be rapidly searched for new leads. This represents a breakthrough compared to the long and slow, classical drug discovery process which involves testing one molecule at a time.
Enveda has seen substantial funding that is cited to help progress multiple platform-derived molecules to the clinic, allowing the company to apply its discovery technology to the drug development stages - with targets including inflammation, fibrosis, and neurosensory disorders. With investors including leaders in biotech and technology, it is clear the company is exciting the space and has the potential to make great impact in the future.
Freddie
Company Specialist at Welcome to the Jungle
Insights
33% employee growth in 12 months
Company
Funding (last 2 of 9 rounds)
Sep 2025
$150m
SERIES D
Feb 2025
$20m
SERIES C
Total funding: $521.8m
Company benefits
- Work-Life Harmony: We believe people are human beings, not human doings. We work hard, but we rest hard too.
- Weeklong Company Break: The entire company closes for a week at the end of the year, to give everyone a chance to recharge.
- Flexible PTO: We encourage frequent use of your flexible PTO - and we celebrate taking breaks.
- Paid Parental Leave: 12 weeks for all parents.
- Adoption Assistance: Receive support in growing your family.
- Work-from-Home Stipend: Get what you need to do your best work.
Company HQ
Boulder, CO
Leadership
Viswa Colluru, PhD
(Founder & CEO)Prior to founding Enveda in 2019, Viswa spent over 2 years at Recursion Pharmaceuticals in various roles, including Project Leader and Senior Product Manager in Assets & Translation.
Share this job